BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,737,726 | -6.8% | 280,155 | +18.7% | 0.00% | -25.0% |
| Q2 2023 | $7,227,024 | 0.0% | 236,023 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,227,024 | -25.6% | 236,023 | -5.0% | 0.00% | -20.0% |
| Q4 2022 | $9,718,952 | -99.7% | 248,503 | +322.7% | 0.01% | +150.0% |
| Q3 2022 | $2,800,756,000 | +10.7% | 58,790 | -10.1% | 0.00% | +100.0% |
| Q2 2022 | $2,530,395,000 | -1.4% | 65,368 | +46.0% | 0.00% | 0.0% |
| Q1 2022 | $2,565,722,000 | -20.4% | 44,777 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $3,224,257,000 | -6.5% | 40,460 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $3,449,076,000 | -29.0% | 39,640 | +5.0% | 0.00% | -50.0% |
| Q2 2021 | $4,858,030,000 | +234.4% | 37,744 | +107.9% | 0.00% | +100.0% |
| Q1 2021 | $1,452,807,000 | +36.5% | 18,151 | +39.2% | 0.00% | – |
| Q4 2020 | $1,064,422,000 | – | 13,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |